Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2013
02/07/2013US20130036520 USE OF DIG3 INSECTICIDAL CRYSTAL PROTEIN IN COMBINATION WITH Cry1Ab FOR MANAGEMENT OF RESISTANCE IN EUROPEAN CORNBORER
02/07/2013US20130036519 Compositions and Methods for the Control of Root Lesion Nematode
02/07/2013US20130036518 Organism with altered carotenoid content and method of producing same
02/07/2013US20130036516 Plants having enhanced yield-related traits and method for making the same
02/07/2013US20130036514 Soybean variety a1026436
02/07/2013US20130036513 Soybean variety a1026256
02/07/2013US20130036512 Soybean variety a1026366
02/07/2013US20130036511 Soybean variety a1026437
02/07/2013US20130036510 Soybean variety a1026434
02/07/2013US20130036509 Soybean variety a1026419
02/07/2013US20130036508 Soybean variety a1026417
02/07/2013US20130036507 Soybean variety a1026415
02/07/2013US20130036506 Soybean variety a1026413
02/07/2013US20130036505 Soybean variety a1026402
02/07/2013US20130036504 Soybean variety a1026397
02/07/2013US20130036503 Soybean variety a1026361
02/07/2013US20130036502 Soybean variety a1026344
02/07/2013US20130036501 Soybean variety a1026335
02/07/2013US20130036500 Soybean variety a1026332
02/07/2013US20130036499 Soybean variety a1026330
02/07/2013US20130036498 Soybean variety d2011912
02/07/2013US20130036497 Soybean variety a1026311
02/07/2013US20130036496 Soybean variety s100306
02/07/2013US20130036495 Soybean variety a1026289
02/07/2013US20130036494 Soybean variety d2011911
02/07/2013US20130036493 Soybean variety s100305
02/07/2013US20130036492 Soybean variety a1026142
02/07/2013US20130036491 Soybean variety a1026154
02/07/2013US20130036490 Soybean variety a1026150
02/07/2013US20130036489 Soybean variety a1026138
02/07/2013US20130036488 Soybean variety d2011909
02/07/2013US20130036487 Pepper hybrid svr 11368833
02/07/2013US20130036486 Bean line fivc6v0999
02/07/2013US20130036485 Bean line fivc6v0998
02/07/2013US20130036484 Bean line fivc6v1002
02/07/2013US20130036483 Bean line fivc6v1001
02/07/2013US20130036482 Method for assessment of potential for development of dravet syndrome and use thereof
02/07/2013US20130036481 Use of perlecan domain v in treating amyloidogenic disease
02/07/2013US20130035755 Medical device with coating that promotes endothelial cell adherence
02/07/2013US20130035513 Methods and compositions for enhanced production of fatty aldehydes and fatty alcohols
02/07/2013US20130035472 Method of producing transcripts using cryptic splice sites
02/07/2013US20130035403 Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids
02/07/2013US20130035397 Anti-Viral Compounds
02/07/2013US20130035388 Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex
02/07/2013US20130035382 Anti-Viral Compounds
02/07/2013US20130035374 MicroRNA induction of pluripotential stem cells and uses thereof
02/07/2013US20130035373 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
02/07/2013US20130035372 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
02/07/2013US20130035371 Lipid formulated dsrna targeting the pcsk9 gene
02/07/2013US20130035370 Compositions and methods for modulation of lmna expression
02/07/2013US20130035369 Double strand compositions comprising differentially modified strands for use in gene modulation
02/07/2013US20130035349 Pyrazolopyrimidinone kinase inhibitor
02/07/2013US20130035348 Antimetastatic compounds
02/07/2013US20130035345 Solid dispersion formulations and methods of use thereof
02/07/2013US20130035327 Modulators of ATP-Binding Cassette Transporters
02/07/2013US20130035324 Heterocyclic compounds and uses thereof
02/07/2013US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
02/07/2013US20130035287 Transient immortalization
02/07/2013US20130035260 Genes involved in inflammatory bowel diseases and use thereof
02/07/2013US20130035256 Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods
02/07/2013US20130035241 Key genes, micrornas, other non-coding rnas and combination thereof for identifying and regulating the pluripotent status of cells
02/07/2013US20130035233 Novel herbicide resistance genes
02/07/2013US20130034906 Methods for in vitro oocyte maturation
02/07/2013US20130034905 Method for making culture medium
02/07/2013US20130034904 Culture medium
02/07/2013US20130034903 Method for culturing neural cells using culture medium
02/07/2013US20130034902 Fusion Polypeptides Capable of Activating Receptors
02/07/2013US20130034901 Use of a Proteolytic Enzyme for the Modification of the Cell Surface of a Stem Cell
02/07/2013US20130034900 Reprogrammation of eukaryotic cells with engineered microvesicles
02/07/2013US20130034899 Cell culturing device using electrical responsiveness functional material, cell culturing system including the same, and cell culturing method
02/07/2013US20130034894 Novel allene oxide synthase derived from lemna paucicostata
02/07/2013US20130034878 Chondroitin Synthase, Method for Producing The Same and Method for Producing Saccharide Chain-Extended Chondroitin
02/07/2013US20130034875 Dna construct, and process for production of recombinant cho cell using same
02/07/2013US20130034599 Synthetic nanostructures including nucleic acids and/or other entities
02/07/2013US20130034598 Inhibitors of akt/pkb with anti-tumor activity
02/07/2013US20130034581 Genetically engineered swine influenza virus and uses thereof
02/07/2013US20130034576 Novel adenovirus isolated from titi monkeys
02/07/2013US20130034574 Modified melk peptides and vaccines containing the same
02/07/2013US20130034564 Anti-rsv g protein antibodies
02/07/2013US20130034561 Isolated mammalian monocyte cell genes; related reagents
02/07/2013US20130034559 Targeted Binding Agents Against B7-H1
02/07/2013US20130034558 Epidermal growth factor receptor variant
02/07/2013US20130034554 Antibodies to il-6 and use thereof
02/07/2013US20130034551 Wnt Antagonists and Methods of Treatment and Screening
02/07/2013US20130034543 Modulating xrn1
02/07/2013US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment
02/07/2013US20130034528 New methods for isolating tr1 cells
02/07/2013US20130034527 Mitochondrial enhancement of cells
02/07/2013US20130034526 Populations of pancreatic progenitor cells and methods of isolating and using same
02/07/2013US20130034525 Beta iselets-like cells derived from whole bone marrow
02/07/2013US20130034524 Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate
02/07/2013US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use
02/07/2013CA2843896A1 Collagen 7 and related methods
02/07/2013CA2843386A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
02/07/2013CA2843373A1 Composition for embryo culture
02/07/2013CA2842954A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders
02/07/2013CA2842872A1 Recombinant swine influenza virus and uses thereof
02/07/2013CA2842368A1 Switch costimulatory receptors
02/07/2013CA2842092A1 Method for identification and isolation of terminator sequences causing enhanced transcription
02/07/2013CA2841985A1 Metabolic maturation in stem cell-derived tissue cells